Comment

摘要

This year has seen something of a comeback for big mergers and acquisitions (M&A) with The Economist counting 15 transactions worth over US$ 15 billion so far and a number still in the pipeline. Pfizer's whopping US$ 98.7 billion offer for its UK rival, AstraZenica, currently tops the charts, while in the energy space, GE's bid for the power business of Alstom, a French engineering firm, is valued at US$ 17.1 billion.